MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Ownership - Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
594
Web
https://www.crinetics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.73B
P/E Ratio
N/A
Total Cash
1.29B
Projected Growth
N/A
Total Debt
47.86M
Revenue
18.07M
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash/Share
12.25
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CRNX
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
594
Web
https://www.crinetics.com